Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher
Hospira Inc. (HSP) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 17% in the past one-month time frame.
This provider of injectable pharmaceutical drugs and infusion technologies has seen two negative estimate revisions in the last 30 days. The Zacks Consensus Estimate has also moved lower over the same period. This implies trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can last.
Hospira currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks worth considering in the medical products industry are GW Pharmaceuticals plc (GWPH), ICU Medical, Inc. (ICUI) and Abaxis, Inc. (ABAX). While GW Pharmaceuticals sports a Zacks Rank #1 (Strong Buy), ICU Medical and Abaxis carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
HOSPIRA INC (HSP): Free Stock Analysis Report
GW PHARMACEUTICALS PLC ADS (GWPH): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
ABAXIS CP (ABAX): Free Stock Analysis Report
Zacks Investment Research
